Developing E-liquid Product Standards (Sweet Spot Study)

NCT05864586 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2025-04-10

Study results available
· View outcomes & findings →

Summary

The Sweet Spot Study aims to evaluate the effect of e-liquids with nicotine varying in freebase (FB) levels and concentrations on the appeal of electronic cigarettes (ECs) in young adult EC users with minimal/no history of smoking and older adult smokers.

Conditions

  • Nicotine
  • Nicotine Vaping
  • E-cigarette Use

Interventions

BEHAVIORAL

Vaping study EC A

Vaping two puffs using the study EC device

BEHAVIORAL

Vaping study EC B

Vaping two puffs using the study EC device

BEHAVIORAL

Vaping study EC C

Vaping two puffs using the study EC device

BEHAVIORAL

Vaping study EC D

Vaping two puffs using the study EC device

BEHAVIORAL

Vaping study EC E

Vaping two puffs using the study EC device

BEHAVIORAL

Vaping study EC F

Vaping two puffs using the study EC device

BEHAVIORAL

Vaping study EC G

Vaping two puffs using the study EC device

BEHAVIORAL

Vaping study EC H

Vaping two puffs using the study EC device

BEHAVIORAL

Vaping study EC I

Vaping two puffs using the study EC device

BEHAVIORAL

Vaping study EC J

Vaping two puffs using the study EC device

Sponsors & Collaborators

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Theodore L Wagener, PhD · Ohio State University Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-30
Primary Completion
2024-02-26
Completion
2024-02-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05864586 on ClinicalTrials.gov